Literature DB >> 11298125

Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis.

T Kühbacher1, P Gionchetti, J Hampe, U Helwig, P Rosenstiel, M Campieri, H J Buhr, S Schreiber.   

Abstract

Activation of signal transducer and activator of transcription 1 (STAT1) is a hallmark of IFN-gamma receptor signal transduction but is also part of the signalling pathway of other cytokines/growth factor receptors. In ulcerative colitis, high levels of activation and expression of STAT1 have been observed in comparison with both Crohn's Disease and normal controls. Pouchitis develops in some patients after Ileal-Pouch-Anal-Anastomosis (IPAA). The pathophysiology and aetiology of pouchitis is still unclear. Recent studies have shown an increased production of proinflammatory cytokines including IFN-gamma. To investigate the expression and activation of STAT1 in pouchitis and the influence of treatment, patients were followed longitudinally from pouch operation. Diagnosis of pouchitis was made by clinical, endoscopic and histological criteria. Biopsies were obtained during routine endoscopy and snap frozen in liquid nitrogen. Nuclear and cytosolic extracts were prepared and the expression and activation of specific transcription factors were assessed by Western blot, electrophoretic mobility shift assay and immunofluorescence. Patients who develop pouchitis show highly increased levels of STAT1 alpha as well as STAT1 beta expression and activation in comparison with both normal pouch and normal ileal mucosa. Improvement of pouchitis during antibiotic therapy relates to a normalization of STAT1 expression and activation. We conclude that activation of STAT1 correlates to clinical disease activity and therefore STAT1 could play an important role in the pathophysiology of pouchitis. Similarities in the pattern of activation of STAT1 in pouchitis and ulcerative colitis may suggest a common pathway in the immunopathophysiology of both diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298125      PMCID: PMC1906014          DOI: 10.1046/j.1365-2249.2001.01455.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Activation of nuclear factor kappa B inflammatory bowel disease.

Authors:  S Schreiber; S Nikolaus; J Hampe
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

2.  Ileostomy.

Authors:  N G Kock; N Darle; L Hultén; J Kewenter; H Myrvold; B Philipson
Journal:  Curr Probl Surg       Date:  1977-08       Impact factor: 1.909

3.  Measurement of protein-DNA interaction parameters by electrophoresis mobility shift assay.

Authors:  M G Fried
Journal:  Electrophoresis       Date:  1989 May-Jun       Impact factor: 3.535

4.  Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum.

Authors:  Y R Mahida; S Patel; P Gionchetti; D Vaux; D P Jewell
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

5.  Proctocolectomy without ileostomy for ulcerative colitis.

Authors:  A G Parks; R J Nicholls
Journal:  Br Med J       Date:  1978-07-08

6.  Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

Authors:  P Gionchetti; F Rizzello; A Venturi; F Ugolini; M Rossi; P Brigidi; R Johansson; A Ferrieri; G Poggioli; M Campieri
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

7.  Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis.

Authors:  A Stallmach; F Schäfer; S Hoffmann; S Weber; I Müller-Molaian; T Schneider; G Köhne; K W Ecker; G Feifel; M Zeitz
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

Review 8.  Pouchitis: pathophysiology and treatment.

Authors:  T Kühbacher; S Schreiber; N Runkel
Journal:  Int J Colorectal Dis       Date:  1998       Impact factor: 2.571

9.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.

Authors:  G Rogler; K Brand; D Vogl; S Page; R Hofmeister; T Andus; R Knuechel; P A Baeuerle; J Schölmerich; V Gross
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  10 in total

1.  Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  R F Leal; M L S Ayrizono; M Milanski; A Coope; J J Fagundes; L A Velloso; C S R Coy
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

2.  Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?

Authors:  Nielce M de Paiva; Maria L S Ayrizono; Marciane Milanski; Andressa Coope; Luiza M F Oliveira; João J Fagundes; Lício A Velloso; Cláudio S R Coy; Raquel F Leal
Journal:  Int J Clin Exp Med       Date:  2011-09-15

Review 3.  Pouchitis: insight into the pathogenesis and clinical aspects.

Authors:  Leandro Minatel Vidal de Negreiros; Lívia Bitencourt Pascoal; Lívia Moreira Genaro; Julian Furtado Silva; Bruno Lima Rodrigues; Michel Gardere Camargo; Carlos Augusto Real Martinez; Cláudio Saddy Rodrigues Coy; Maria de Lourdes Setsuko Ayrizono; João José Fagundes; Raquel Franco Leal
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

4.  Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions.

Authors:  Giuseppe Mazzarella; Thomas T MacDonald; Virginia M Salvati; Peter Mulligan; Luigi Pasquale; Rosita Stefanile; Paolo Lionetti; Salvatore Auricchio; Francesco Pallone; Riccardo Troncone; Giovanni Monteleone
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

5.  CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue.

Authors:  Ulf Helwig; Paolo Gionchetti; Fernando Rizzello; Karen Lammers; Tanja Kühbacher; Stefan Schreiber; Marco Baggiolini; Mariagrazia Uguccioni; Massimo Campieri
Journal:  Int J Colorectal Dis       Date:  2003-06-25       Impact factor: 2.571

Review 6.  Macrophages and the Recovery from Acute and Chronic Inflammation.

Authors:  Kajal Hamidzadeh; Stephen M Christensen; Elizabeth Dalby; Prabha Chandrasekaran; David M Mosser
Journal:  Annu Rev Physiol       Date:  2016-12-07       Impact factor: 19.318

7.  Leukocytapheresis for the treatment of active pouchitis: a pilot study.

Authors:  Yasumi Araki; Keiichi Mitsuyama; Takaaki Nagae; Yuji Tou; Motonori Nakagawa; Yasue Iwatani; Masakazu Harada; Hiroyuki Ozasa; Michio Sata; Toshihiro Noake
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

Review 8.  Infliximab for the treatment of pouchitis.

Authors:  Maddalena Zippi; Claudio Cassieri; Eleonora Veronica Avallone; Roberta Pica
Journal:  World J Clin Cases       Date:  2013-09-16       Impact factor: 1.337

Review 9.  The regulation of inflammation by interferons and their STATs.

Authors:  Isabella Rauch; Mathias Müller; Thomas Decker
Journal:  JAKSTAT       Date:  2013-01-01

10.  The relationship between preoperative T helper cytokines in the ileal mucosa and the pathogenesis of pouchitis.

Authors:  Takahito Kitajima; Yoshiki Okita; Mikio Kawamura; Satoru Kondo; Yuji Toiyama; Keiichi Uchida; Masato Kusunoki
Journal:  BMC Gastroenterol       Date:  2020-08-18       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.